Literature DB >> 25258321

Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).

Jin Qi1, Lei Huo2, Yiwei Tony Zhu3, Yi-Jun Zhu4.   

Abstract

ASH2L is a component of MLL complexes that confer H3K4 trimethylation. The ASH2L gene is located at 8q11-12, which is often amplified in breast cancers. We found that increased ASH2L expression, which can result from gene amplification, is often correlated with increased ERα expression in both breast cancer cell lines and primary breast cancers. Forced expression of ASH2L induced ERα expression in mammary epithelial cells, whereas depletion of ASH2L suppressed ERα expression in breast cancer cells. To understand the mechanism by which ASH2L regulates ERα expression, we identified GATA3 as the binding protein of ASH2L. ASH2L was shown to potentiate the transcriptional activity of GATA3. ASH2L was recruited to the enhancer of the ERα gene through GATA3 to promote ERα transcription. This study established that ASH2L enhances ERα expression as a coactivator of GATA3 in breast cancers.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Breast Cancer; Estrogen Receptor; GATA Transcription Factor; Gene Regulation; Oncogene

Mesh:

Substances:

Year:  2014        PMID: 25258321      PMCID: PMC4223337          DOI: 10.1074/jbc.M114.579839

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  The diverse functions of histone lysine methylation.

Authors:  Cyrus Martin; Yi Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

Review 2.  Developmental control via GATA factor interplay at chromatin domains.

Authors:  Emery H Bresnick; Melissa L Martowicz; Saumen Pal; Kirby D Johnson
Journal:  J Cell Physiol       Date:  2005-10       Impact factor: 6.384

Review 3.  The biology of breast cancer.

Authors:  S J Nass; N E Davidson
Journal:  Hematol Oncol Clin North Am       Date:  1999-04       Impact factor: 3.722

Review 4.  A COMPASS in the voyage of defining the role of trithorax/MLL-containing complexes: linking leukemogensis to covalent modifications of chromatin.

Authors:  Kristen Tenney; Ali Shilatifard
Journal:  J Cell Biochem       Date:  2005-06-01       Impact factor: 4.429

5.  A novel non-SET domain multi-subunit methyltransferase required for sequential nucleosomal histone H3 methylation by the mixed lineage leukemia protein-1 (MLL1) core complex.

Authors:  Anamika Patel; Valarie E Vought; Venkatasubramanian Dharmarajan; Michael S Cosgrove
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

6.  Comprehensive profiling of 8p11-12 amplification in breast cancer.

Authors:  Véronique Gelsi-Boyer; Béatrice Orsetti; Nathalie Cervera; Pascal Finetti; Fabrice Sircoulomb; Carole Rougé; Laurence Lasorsa; Anne Letessier; Christophe Ginestier; Florence Monville; Séverine Esteyriès; José Adélaïde; Benjamin Esterni; Catherine Henry; Stephen P Ethier; Frédéric Bibeau; Marie-Joëlle Mozziconacci; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; François Bertucci; Daniel Birnbaum; Charles Theillet; Max Chaffanet
Journal:  Mol Cancer Res       Date:  2005-12       Impact factor: 5.852

7.  A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.

Authors:  Maria J Garcia; Jessica C M Pole; Suet-Feung Chin; Andrew Teschendorff; Ali Naderi; Hilal Ozdag; Maria Vias; Tanja Kranjac; Tatiana Subkhankulova; Claire Paish; Ian Ellis; James D Brenton; Paul A W Edwards; Carlos Caldas
Journal:  Oncogene       Date:  2005-08-04       Impact factor: 9.867

8.  Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer.

Authors:  J Adélaïde; M Chaffanet; A Imbert; F Allione; J Geneix; C Popovici; D van Alewijk; J Trapman; R Zeillinger; A L Børresen-Dale; R Lidereau; D Birnbaum; M J Pébusque
Journal:  Genes Chromosomes Cancer       Date:  1998-07       Impact factor: 5.006

9.  An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain.

Authors:  Fang Cao; Yong Chen; Tomasz Cierpicki; Yifan Liu; Venkatesha Basrur; Ming Lei; Yali Dou
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

10.  ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.

Authors:  Fabrice Sircoulomb; Nathalie Nicolas; Anthony Ferrari; Pascal Finetti; Ismahane Bekhouche; Estelle Rousselet; Aurélie Lonigro; José Adélaïde; Emilie Baudelet; Séverine Esteyriès; Julien Wicinski; Stéphane Audebert; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Marc Lopez; Jean-Paul Borg; Christos Sotiriou; Cornel Popovici; François Bertucci; Daniel Birnbaum; Max Chaffanet; Christophe Ginestier
Journal:  EMBO Mol Med       Date:  2011-02-15       Impact factor: 12.137

View more
  8 in total

1.  Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.

Authors:  Noriko Kanaya; George Somlo; Jun Wu; Paul Frankel; Masaya Kai; Xueli Liu; Shang Victoria Wu; Duc Nguyen; Nymph Chan; Meng-Yin Hsieh; Michele Kirschenbaum; Laura Kruper; Courtney Vito; Behnam Badie; John H Yim; Yuan Yuan; Arti Hurria; Chu Peiguo; Joanne Mortimer; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-03       Impact factor: 4.292

Review 2.  Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers.

Authors:  Aman Kumar; Niti Kumari; Nayudu Nallabelli; Rajendra Prasad
Journal:  Indian J Clin Biochem       Date:  2019-04-03

3.  GATA3 inhibits GCM1 activity and trophoblast cell invasion.

Authors:  Yueh Ho Chiu; Hungwen Chen
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

Review 4.  Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin.

Authors:  Agnieszka Bochyńska; Juliane Lüscher-Firzlaff; Bernhard Lüscher
Journal:  Cells       Date:  2018-03-02       Impact factor: 6.600

5.  Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells.

Authors:  Giovanni Nassa; Annamaria Salvati; Roberta Tarallo; Valerio Gigantino; Elena Alexandrova; Domenico Memoli; Assunta Sellitto; Francesca Rizzo; Donatella Malanga; Teresa Mirante; Eugenio Morelli; Matthias Nees; Malin Åkerfelt; Sara Kangaspeska; Tuula A Nyman; Luciano Milanesi; Giorgio Giurato; Alessandro Weisz
Journal:  Sci Adv       Date:  2019-02-06       Impact factor: 14.136

6.  Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.

Authors:  Jonathan C Irish; Jamie N Mills; Brittany Turner-Ivey; Robert C Wilson; Stephen T Guest; Alexandria Rutkovsky; Alan Dombkowski; Christiana S Kappler; Gary Hardiman; Stephen P Ethier
Journal:  Mol Oncol       Date:  2016-02-27       Impact factor: 6.603

7.  LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.

Authors:  Shi-Qin Liu; Zhi-Yang Zhou; Xue Dong; Lei Guo; Ke-Jing Zhang
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

8.  The plasma peptides of breast versus ovarian cancer.

Authors:  Jaimie Dufresne; Pete Bowden; Thanusi Thavarajah; Angelique Florentinus-Mefailoski; Zhuo Zhen Chen; Monika Tucholska; Tenzin Norzin; Margaret Truc Ho; Morla Phan; Nargiz Mohamed; Amir Ravandi; Eric Stanton; Arthur S Slutsky; Claudia C Dos Santos; Alexander Romaschin; John C Marshall; Christina Addison; Shawn Malone; Daren Heyland; Philip Scheltens; Joep Killestein; Charlotte Teunissen; Eleftherios P Diamandis; K W M Siu; John G Marshall
Journal:  Clin Proteomics       Date:  2019-12-23       Impact factor: 3.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.